Comparator: rosuvastatin
Sponsors
Organon and Co, Sunnybrook Health Sciences Centre
Conditions
Hypercholesterolemia
Phase 3
Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058)
CompletedNCT00090298
Start: 2004-04-30End: 2004-12-31Updated: 2024-08-15
A 12 Week Study of MK0653A in Patients Who Have Been Hospitalized for a Possible Heart Problem (0653A-808)
CompletedNCT00132717
Start: 2005-01-01End: 2007-06-01Updated: 2024-08-15
A Study to Determine the Number of Patients Who Reach Optimal Cholesterol Levels on Each of Three Different Treatments (0653A-121)
CompletedNCT00462748
Start: 2007-03-31End: 2008-06-30Updated: 2024-05-16
INdians Followed for INtensive Lipid Lowering Treatment and Its safetY
TerminatedNCT00664469
Start: 2007-08-31End: 2010-11-30Updated: 2011-07-28
MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162)
CompletedNCT01154036
Start: 2010-07-31End: 2012-10-31Updated: 2022-02-09